{"groups":[{"description":"Chemotherapy or chemotherapy + total body irradiation\n\nStandard of care (SOC) chemotherapy or ( SOC) chemotherapy + total body irradiation (TBI) of one of the following regimens:\n\nRegimen I: Patients receive fludarabine phosphate IV and busulfan IV.\n\nRegimen II: Patients undergo total body irradiation (TBI) twice daily for 8 fractions and receive etoposide IV.\n\nRegimen III: Patients undergo TBI once or twice daily for 11 fractions and receive cyclophosphamide IV.\n\nRegimen IV: Patients undergo TBI and receive fludarabine phosphate IV and busulfan IV.\n\nRegimen V: Patients receive carmustine IV, etoposide IV, cytarabine IV, and melphalan IV. Some patients also receive rituximab IV.\n\nRegimen VI: Patients receive fludarabine phosphate IV and melphalan IV. Some patients also undergo TBI.","id":"FG000","title":"Conditioning Regimen"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Refused further treatment"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"48"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"47"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}